Alzheimer's Drug Discovery Foundation Funds P2D to Develop Anti-Alzheimer's Disease Drug
Alzheimer's Drug Discovery Foundation Funds Varinel to Develop Drugs for Neurodegenerative Disease
OSTA Receives Funding from Institute for the Study of Aging
Cellumen Partners with Alzheimer's Drug Discovery Foundation to Develop New Assays for Early Treatment of Alzheimer's
RemeGenix Funded by the Alzheimer's Drug Discovery Foundation to commercialize BRI2 peptides for use in treating Alzheimer's disease
OLIGOMERIX funded by the Alzheimer's Drug Discovery Foundation to evaluate compounds active against tau oligomers, a novel target for therapeutic development